Biomarkers show promise for identifying early risk of pancreatic cancer

by

A research team at Duke Health has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign.

Leave A Comment

Your email address will not be published. Required fields are marked *